As the principal national public voice for ophthalmology in Canada, the Canadian Ophthalmological Society (COS) plays a critical role in advocating for optimal eye care for all Canadians.

Representing eye physicians and surgeons from coast to coast, COS strategically collaborates with governments, industry partners and health care allies on a wide range of advocacy issues, including stronger vision standards, improved federal regulations, and shorter wait times for speciality eye surgeries.

Monday May 14, 2018

Everything you need to know about sun safety for kids

“Children’s eyes are particularly vulnerable to the sun’s UV rays, as their ocular lenses are still developing and cannot filter UV light in the same way as an adult’s can, Dr. Christine Law, a pediatric ophthalmologist and spokesperson for the Canadian Ophthalmological Society told HuffPost Canada.”Huff Post

Read More

Thursday May 10, 2018

Preventing and treating the leading cause of blindness for seniors: AMD

“It’s important we educate ourselves about AMD and the steps we can take to reduce vision loss with these tips from the Canadian Ophthalmological Society (COS) and Canadian Retina Society (CRS).”Forever Young

Read More

Wednesday May 2, 2018

Joint letter from COS, CGS, CRS, CUS, and CAPOS on atropine 1% discontinuation

Mr. Kyle SteigerVP Ophthalmology FranchiseNovartis Pharmaceuticals Canada Inc.385 Bouchard Blvd.Dorval QC H9S 1A9 Mr. Stu FowlerGM Alcon CanadaAlcon Canada Inc.2665 Meadowpine Blvd.Mississauga ON L5N 8C7 Dear Mr. Steiger and Mr. Fowler, Following the letter that the Canadian Ophthalmological Society (COS) sent you on March 26, 2018 regarding the impact Novartis/Alcon’s decision to discontinue Isopto Atropine […]

Read More

Tuesday May 1, 2018

Study shows only half of Canadians seek treatment for symptoms of potential eye disease that may lead to vision loss

The Canadian Ophthalmological Society sheds light onto Canadian eye health behaviours during National Vision Health Month A new survey, commissioned by the Canadian Ophthalmological Society (COS), revealed the majority of Canadians (59 per cent) experience symptoms of potential eye disease, yet only half of these people (54 per cent) reported they had seen a health […]

Read More

Friday April 20, 2018

Shortage of fluorescein strips is over

Dear COS member, We are pleased to inform you that the shortage of DioFluor (fluorescein) strips is over. We have received confirmation from INNOVA Medical Ophthalmics and Dioptic Pharmaceuticals that DioFluor strips are now available and the company has started shipping them as of April 17, 2018. As you know, the COS has been working […]

Read More

Friday March 23, 2018

Atropine 1% discontinuation: member alert

Dear COS Member, As some of you may know, Novartis/Alcon has announced that it is discontinuing Isopto Atropine 1%. Currently, Isopto Atropine 1% is listed as an “actual shortage” on the Drug Shortages Canada database, and Health Canada was unaware of the discontinuation when we reached out to them. Consequently, this announcement has caused some […]

Read More

- Minimize

+ Maximize